Acelrx Pharmaceuticals Inc

NASDAQ:ACRX 3:59:54 PM EDT

1.03

-0.06 (-5.50%)

7:16:18 PM EDT: $1.01 -0.02 (-1.94%)

Market Cap (Intraday)	10.63M
Current PE	0.20
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.04 Million
Adjusted EPS	-$0.51

See more estimates

10-Day MA	$0.96
50-Day MA	$0.75
200-Day MA	$2.41

See more pivots

Acelrx Pharmaceuticals Inc Stock, NASDAQ:ACRX

25821 Industrial Boulevard, Suite 400, Hayward, California 94545

United States of America

Phone: +1.650.216.3500

Number of Employees: 19

http://www.acelrx.com

Description

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Hayward, CA.